Kelly Constable is a commercialization expert with over 20 years of experience in the US and Europe at global biotech firms, leading global launch strategies for multiple billion-dollar therapeutics. They have led deals with multinationals and raised equity from venture and multinational investors. They currently serve as Senior Advisor to Lumira Ventures and as Chief Executive Officer of CloudCath. Their past leadership roles include Executive Chairman of Prota Therapeutics Pty Ltd (2018–2021), Chief Operating Officer of CloudCath (2024–2025), and board positions at Genome.One (Board of Directors and CEO, 2017–2018) and Oculo (Board Of Directors, 2020–2021). They are pursuing a Bachelor's Degree in Speech Communication at the University of Tennessee, Knoxville.
This person is not in the org chart
This person is not in any teams
This person is not in any offices